Abbott’s Alere resolves US diagnostic device probe for $33.2 million

Alere has agreed to pay $33.2 million to resolve claims the idea knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.

The Justice Department said which Massachusetts-based Alere, coming from 2006 to 2012, sold its Triage-branded devices to hospitals which government healthcare programs paid for, despite receiving customer complaints about the erroneous results they produced.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

7 − five =